Literatuur

Gottardo NG en Gajjar A (2008) Chemotherapy for malignant brain tumors of childhood. Journal of Child Neurology 23: 1149-1159

Jennekens-Schinkel A & Jennekens FGI (2008) Neuropsychologie van neurologische aandoeningen in de kindertijd. Amsterdam: Uitgeverij Boom. Hoofdstuk 8. Hersentumoren en cerebrale leukemie, pp 313, 315

Huber JF, Bradley K, Spiegler BJ Dennis M (2006) Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. Child’s Nervous System 22: 132-138

Knight KR, Kraemer DF, Neuvelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. Journal of Clinical Oncology 23: 8588-8596

Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. Journal of clinical Oncology 26: 1112-1118

Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. Journal of Clinical Oncology 23: 2256-2263

Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. Journal of Clinical Oncology 23: 5511-5519

Palmer SL (2008) Neurodevelopmental impacts on children treated for medulloblastoma: a review and proposed conceptual model. Developmental Disability Research Reviews 14: 203-210

Puget S, Boddaert N, Viguier N, Kieffer V, Bulteau C, Garnett M, Callu D, Sainte-Rose D, Kalifa C, Dellatolas G, Grill J (2009) Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant fossa posterior tumors. Cancer 115: 1338-1347

Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E, Grotzer MA (2005) Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics 36: 357-365

Riva D, Giorgi C (2000) The cerebellum contributes to higher functions during development. Brain 123: 1051-1061

Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC. The Children’s Oncology Group (2006) Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study of the Children’s Oncology Group. Journal of Neurosurgery 105 (6 Suppl) 444-451

Uziel T, Karginov FV, Xie S, Parker JS, Wang Y-D, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, Roussel MF (2009) The miR-17-92 cluster collaborates with the Sonie Hedgehog pathway in medulloblastoma. Proceedings of the National Academy of Sciences of the USA 106 (B) 2812-2817

Wells EM, Walsh KS, Khademian ZP, Keating RF, Packer RJ (2008) The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebeallar cognitive affective disorder. Developmental Disabilities 14: 221-228

Wolfe-Christensen C, Mullins LL, Scott JG, McNall-Knapp RY (2007) Persistent psychosocial problems in children who develop posterior fossa syndrome after medulloblastoma resection. Pediatric Blood Cancer 15: 49: 723-726